DBSA Tennessee Past President, S.L. Brannon
share
  • Home
  • About
  • FIRST BOOK: Two Agreements
  • My new book: A Brand New Day
  • Advocacy
    • Letters to our Governor
    • Advocacy Action Items for DBSA Tennessee
    • Submitted Relative Articles
  • Network Resources
  • Additional Events
  • I\\\\\'ve been there
  • Forums
  • Contacts

NEW Research study shows new path to reduce depression

11/6/2015

0 Comments

 



Study further links immune response, serotonin signaling

by Bill Snyder | Thursday, Nov. 5, 2015, 8:43 AM

​Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.
Their latest discovery, reported this week in the journal Translational Psychiatry, provides further evidence that a signaling pathway involved in the body’s immune response to infection and other stressors can regulate the brain’s control of the neurotransmitter serotonin.
                                                                                           Randy Blakely, Ph.D.


“The inflammatory pathway that we have identified is likely one by which serotonin signaling is regulated in general,” said Randy Blakely, Ph.D., who led the research team. “By targeting this pathway, we might come up with better medications to treat disorders where manipulation of serotonin signaling has proved beneficial, as in depression.”
For the better part of a decade, Blakely and his colleagues have investigated the p38alpha MAPK signaling pathway. MAPKs, or mitogen-activated protein kinases, are enzymes that regulate the body’s response to infection and other stress stimuli, among other roles.
The latest findings add to an increasing body of evidence that the p38alpha MAPK pathway links the body’s immune response to regulation of the brain serotonin transporter. The transporter, which eliminates serotonin from the synapse, or gap between nerve cells, is the target for a major class of anti-depressants.
Selective serotonin reuptake inhibitors or SSRIs like Prozac increase the brain’s supply of serotonin by blocking the transporter. But it can take weeks to achieve a therapeutic effect, and not everyone responds to them.
Using genetic mouse models they developed, Blakely and his colleagues showed that the MAPK pathway acts in serotonin neurons to communicate signs of infection in the periphery. That leads to an elevation in serotonin transporter activity and multiple serotonin-linked behaviors.
“The net consequence of p38alpha MAPK activation is … we get elevated transporter activity that can drain away the serotonin,” said Blakely, the Allan D. Bass Professor of Pharmacology and Psychiatry.
The impact on behavior was profound. When an inflammatory response was produced by peripheral injection of a piece of bacteria in mice, their serotonin neurons showed rapid activation of the p38alpha MAPK pathway. The animals also exhibited depressive-like behaviors, including signs of heightened anxiety and despair.
But when, in the current study, the p38alpha MAPK pathway was genetically “knocked out,” specifically in serotonin neurons, these behaviors were extinguished. The inflammatory agent had no effect. The animals were, as Blakely described them, “resilient.”
This “is a response to an acute inflammatory agent,” Blakely cautioned. It says nothing about what may occur in chronic inflammatory states. “That’s something we’re eager to pursue with the same kind of genetic approach,” he said.
At the same time, “I doubt that (this MAPK pathway) has evolved only to respond to inflammation,” he said.
Since the p38alpha MAPK pathway has the ability to turn up and turn down the activity of the serotonin transporter, “maybe if we targeted the way (it) regulates the transporter as opposed to blocking the transporter itself, we might have a better antidepressant,” Blakely said.
Blakely is director of the Vanderbilt/NIMH Silvio O. Conte Center for Neuroscience Research, which is supported by the National Institute of Mental Health, part of the National Institutes of Health (NIH). First author of the study was Nicole Baganz, Ph.D., a postdoctoral fellow in the Blakely lab.
The research was supported in part by NIH grants NS007491, MH094527 and MH096972, the Brain and Behavioral Research Foundation and the Institute for Psychiatric Neuroscience.
Media Inquiries: 
Bill Snyder, (615) 322-4747  

​

0 Comments



Leave a Reply.

    Author - 

    S.L. Brannon D.Div..

    Editor: numerous contributors are personally invited.

    Archives

    April 2018
    February 2018
    January 2018
    December 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    July 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013

    Categories

    All
    AARP
    Action Alert
    Action-alert
    Advocacy
    Affirmation
    Affordable Care Act
    Allen Doederlein
    Alternative Medicine
    Bad Law
    Bad-law
    Barber Bill Proposal
    Bipolar
    Borderline Personality Disorder
    Bp Magazine
    Branding
    Budget
    Caregivers
    Compassion
    Co Occurring Disorders
    Cooccurring Disorders
    Coping
    Crazy
    DBSA
    Dbsa Tennessee
    Dbsa-tennessee
    Dc
    Dc95f383fe5b
    Death
    Deaths Of Thousands
    Demi Lovato
    Democrat
    Denial
    Depression
    Dual Diagnosis
    Education
    Elected Officals
    Elected-officals
    Forced Commitment
    Grieving
    Health Care
    Health-care
    Health Care Law
    Health-care-law
    Health Reform
    Health-reform
    Help For Depression
    Homelessveterans
    Homeless Veterans
    Hopeworkscommunity
    Huffington Post
    Hurts Most Vulnerable
    Hurts-most-vulnerable
    I'm Here
    Immoral
    Jobs
    Larry Drain
    Leading Researchers And Clinicians
    Legislative Bill
    Legislative-bill
    Malpractice
    Mc Donaldsa18086f9b6
    Medicaid-expansion
    Medications
    Medicine
    Memorial
    Mental Health
    Mental Health Care
    Mental-health-care
    Mental-health-day-on-the-hill
    Mental Health In Tennessee
    Mental-health-in-tennessee
    Mental Health Services
    Mission
    Money
    Mood Disorders
    Moving Backwards
    Moving-backwards
    Murphy-bill-proposal
    National-institues-of-mental-health
    New Laws
    Outstanding-performance
    Parity
    Patient-protection
    Peer-specialist
    Peer Support
    Peer Support Centers
    Peer-support-centers
    Personal Stories
    Personal Story
    Personal-story
    Petition
    Petition-to-save-service-centers
    Politics
    Prejudice
    Proposed Legislative Bill
    Proposed-legislative-bill
    Protected Health Information
    Ptsd
    Pushing Back Against Stigma
    Recovery
    Republican
    Resilience
    Resulting In Death
    Scientific Advisory Board
    Self Advocacy
    Self Help
    Senator Murphy
    Silence
    Social-security
    State Organization
    Steve L Brannon
    Steve L Brannonf11c90eedf
    Stigma
    Suicidal Ideations
    Support Groups
    Teens
    Tennessee Department Of Mental Health And Substance Abuse
    Tennessee-department-of-mental-health-and-substance-abuse
    Tennessee Government
    Tennessee-government
    The Leading Patient Directed National Organization
    The Leading Patientdirected National Organizationf0151a2bc0
    Themighty.com
    Therapy
    U-s-congressman
    Vanderbilt-university
    Veterans
    Veterans-employment
    Victimized
    Vulnerable
    Washington
    Wrap-training
    Youth

    RSS Feed
Proudly powered by Weebly
Photo used under Creative Commons from DominusVobiscum